z-logo
open-access-imgOpen Access
Failure of Primaquine Therapy for the Treatment of Plasmodium ovale Malaria
Author(s) -
Emmanuel Bottieau,
Alfons Van Gompel,
Willy Peetermans
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/497378
Subject(s) - primaquine , medicine , plasmodium ovale , malaria , protozoal disease , plasmodium vivax , chloroquine , intensive care medicine , virology , plasmodium falciparum , immunology
3. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312:338–45. 4. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus beta-lactam–aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997; 41:1127–33. 5. Falagas ME. Monotherapy versus beta-lactam–aminoglycoside combination therapy for gram-negative bacteremia. Antimicrob Agents Chemother 1997; 41:2593–4. 6. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia: a meta-analysis. Lancet Infect Dis 2004; 4:519–27.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom